| Literature DB >> 31530641 |
Peter Rahfeld1,2, Jacob F Wardman2,3, Kevin Mehr4,2, Drew Huff4,2, Connor Morgan-Lang5,6, Hong-Ming Chen4, Steven J Hallam5,6,7,8, Stephen G Withers9,2,3.
Abstract
α-Linked GalNAc (α-GalNAc) is most notably found at the nonreducing terminus of the blood type-determining A-antigen and as the initial point of attachment to the peptide backbone in mucin-type O-glycans. However, despite their ubiquity in saccharolytic microbe-rich environments such as the human gut, relatively few α-N-acetylgalactosaminidases are known. Here, to discover and characterize novel microbial enzymes that hydrolyze α-GalNAc, we screened small-insert libraries containing metagenomic DNA from the human gut microbiome. Using a simple fluorogenic glycoside substrate, we identified and characterized a glycoside hydrolase 109 (GH109) that is active on blood type A-antigen, along with a new subfamily of glycoside hydrolase 31 (GH31) that specifically cleaves the initial α-GalNAc from mucin-type O-glycans. This represents a new activity in this GH family and a potentially useful new enzyme class for analysis or modification of O-glycans on protein or cell surfaces.Entities:
Keywords: N-acetylgalactosamine (alpha-GalNAc); O-glycanase; O-glycoprotein; blood; glycobiology; glycopeptide cleavage; glycoprotein; glycosidase; glycoside hydrolase 109 (GH109); glycoside hydrolase 31 (GH31); human gut microbiome; metagenomic analysis; metagenomics; mucin
Mesh:
Substances:
Year: 2019 PMID: 31530641 PMCID: PMC6827296 DOI: 10.1074/jbc.RA119.010628
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157